Prevention of Cardiovascular Disease in Persons with Type 2 Diabetes Mellitus: Current Knowledge and Rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial
Open Access
- 1 June 2007
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 99 (12), S4-S20
- https://doi.org/10.1016/j.amjcard.2007.03.002
Abstract
No abstract availableKeywords
This publication has 106 references indexed in Scilit:
- Effectiveness and tolerability of simvastatin plus fenofibrate for combined hyperlipidemia (the SAFARI trial)The American Journal of Cardiology, 2005
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998
- Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)The Lancet, 1998
- Ten-year survival after acute myocardial infarction: Comparison of patients with and without diabetesAmerican Heart Journal, 1997
- Long-Term Glycemic Control Relates to Mortality in Type II DiabetesDiabetes Care, 1995
- A Prospective Population-Based Study of Microalbuminuria as a Predictor of Mortality in NIDDMDiabetes Care, 1993
- Development of Macrovascular Diseases in NIDDM Patients in Northern Taiwan: A 4-yr follow-up studyDiabetes Care, 1993
- Final Report on the Aspirin Component of the Ongoing Physicians' Health StudyNew England Journal of Medicine, 1989
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaNew England Journal of Medicine, 1987